Compare CZWI & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CZWI | WHWK |
|---|---|---|
| Founded | 1938 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.8M | 213.2M |
| IPO Year | 2006 | 2017 |
| Metric | CZWI | WHWK |
|---|---|---|
| Price | $21.36 | $2.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $22.25 | $7.71 |
| AVG Volume (30 Days) | 32.0K | ★ 343.9K |
| Earning Date | 10-30-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | 8.96 | ★ 86.02 |
| EPS | ★ 0.50 | N/A |
| Revenue | N/A | ★ $7,145,000.00 |
| Revenue This Year | $6.70 | N/A |
| Revenue Next Year | $10.98 | N/A |
| P/E Ratio | $42.22 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.30 | $1.97 |
| 52 Week High | $24.43 | $5.50 |
| Indicator | CZWI | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 22.41 |
| Support Level | $20.42 | $2.46 |
| Resistance Level | $21.69 | $3.05 |
| Average True Range (ATR) | 0.45 | 0.17 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 40.76 | 1.92 |
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short - term investments; and funds provided from operations.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.